A Journey in Science: Promise, Purpose, Privilege

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2013 Oct 4

PMID 24089245

Citations 1

Authors

Carl Nathan

Affiliations

Soon will be listed here.

Abstract

Real innovations in medicine and science are historic and singular; the stories behind each occurrence are precious. At Molecular Medicine we have established the Anthony Cerami Award in Translational Medicine to document and preserve these histories. The monographs recount the seminal events as told in the voice of the original investigators who provided the crucial early insight. These essays capture the essence of discovery, chronicling the birth of ideas that created new fields of research; and launched trajectories that persisted and ultimately influenced how disease is prevented, diagnosed, and treated. In this volume, the first Cerami Award Monograph, by Carl Nathan, MD, chairman of the Department of Microbiology and Immunology at Weill Cornell Medical College, reflects towering genius and soaring inspiration.

Citing Articles

Macrophage Heterogeneity in the Immunopathogenesis of Tuberculosis.

Marakalala M, Martinez F, Pluddemann A, Gordon S Front Microbiol. 2018; 9:1028.

PMID: 29875747 PMC: 5974223. DOI: 10.3389/fmicb.2018.01028.

References

Luster A, Unkeless J, Ravetch J . Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature. 1985; 315(6021):672-6. DOI: 10.1038/315672a0. View

Stuehr D, Fasehun O, Kwon N, Gross S, Gonzalez J, Levi R . Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 1991; 5(1):98-103. DOI: 10.1096/fasebj.5.1.1703974. View

Wu K, Koo J, Jiang X, Chen R, Cohen S, Nathan C . Improved control of tuberculosis and activation of macrophages in mice lacking protein kinase R. PLoS One. 2012; 7(2):e30512. PMC: 3281035. DOI: 10.1371/journal.pone.0030512. View

Badaro R, FALCOFF E, Badaro F, Carvalho E, Pedral-Sampaio D, Barral A . Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med. 1990; 322(1):16-21. DOI: 10.1056/NEJM199001043220104. View

Srimal S, Nathan C . Purification of macrophage deactivating factor. J Exp Med. 1990; 171(4):1347-61. PMC: 2187851. DOI: 10.1084/jem.171.4.1347. View

Lin G, Li D, de Carvalho L, Deng H, Tao H, Vogt G . Inhibitors selective for mycobacterial versus human proteasomes. Nature. 2009; 461(7264):621-6. PMC: 3172082. DOI: 10.1038/nature08357. View

Stuehr D, Kwon N, Gross S, Thiel B, Levi R, Nathan C . Synthesis of nitrogen oxides from L-arginine by macrophage cytosol: requirement for inducible and constitutive components. Biochem Biophys Res Commun. 1989; 161(2):420-6. DOI: 10.1016/0006-291x(89)92615-6. View

Nathan C, Karnovsky M, David J . Alterations of macrophage functions by mediators from lymphocytes. J Exp Med. 1971; 133(6):1356-76. PMC: 2138934. DOI: 10.1084/jem.133.6.1356. View

MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

10.

Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J, Newport M . Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996; 335(26):1956-61. DOI: 10.1056/NEJM199612263352604. View

11.

Nathan C . Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992; 6(12):3051-64. View

12.

Stuehr D, Gross S, Sakuma I, Levi R, Nathan C . Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med. 1989; 169(3):1011-20. PMC: 2189276. DOI: 10.1084/jem.169.3.1011. View

13.

Ward P, Remold H, David J . Leukotactic factor produced by sensitized lymphocytes. Science. 1969; 163(3871):1079-81. DOI: 10.1126/science.163.3871.1079. View

14.

GRANGER G, Shacks S, Williams T, KOLB W . Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature. 1969; 221(5186):1155-7. DOI: 10.1038/2211155a0. View

15.

Ezekowitz R, Dinauer M, Jaffe H, Orkin S, Newburger P . Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med. 1988; 319(3):146-51. DOI: 10.1056/NEJM198807213190305. View

16.

Nathan C, Cunningham-Bussel A . Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat Rev Immunol. 2013; 13(5):349-61. PMC: 4250048. DOI: 10.1038/nri3423. View

17.

Darwin K, Ehrt S, Gutierrez-Ramos J, Weich N, Nathan C . The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science. 2003; 302(5652):1963-6. DOI: 10.1126/science.1091176. View

18.

Nathan C . Aligning pharmaceutical innovation with medical need. Nat Med. 2007; 13(3):304-8. DOI: 10.1038/nm0307-304. View

19.

Venugopal A, Bryk R, Shi S, Rhee K, Rath P, Schnappinger D . Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. Cell Host Microbe. 2011; 9(1):21-31. PMC: 3040420. DOI: 10.1016/j.chom.2010.12.004. View

20.

Nathan C, Cohn Z . Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages. J Exp Med. 1980; 152(1):198-208. PMC: 2185894. DOI: 10.1084/jem.152.1.198. View